News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
Solid-State, Crystallization, and CMC Control for Drug Development – A Crystal Pharmatech Case Study Series
From early developability to late-stage specifications—polymorph/salt-cocrystal strategy, SCXRD/MicroED solutions, solvent & pathway design, drug-product form control, ASD crystalline-form limits...
Subscribe to be the first to get the updates!